ArticleThe Lancet. Oncology2020
Ivosidenib for advanced IDH1-mutant cholangiocarcinoma.
Lorenzo Gervaso et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2020
Lorenzo Gervaso et al.PubMed ↗Publisher ↗
No numbers read from the abstract.